The global Tissue Diagnostics Market size is expected to
reach USD 6.03 billion by 2025 at a 6.6% CAGR during the forecast period,
according to a new report by Grand View Research, Inc. Major developments
pertaining to consolidation, automation, and efficiency analysis to streamline
tissue-based disease screening protocols and cashflows have driven this market.
Furthermore, collaborations for development of companion diagnostics are anticipated
to impact adoption rate of technologies that are employed in the tissue
diagnostics arena.
Need for robust diagnostic solutions as a
consequence of rising cancer burden has pronounced demand for research
initiatives and simultaneous product launches, thus driving the market. For
example, in March 2017, California-based OptraScan began offering a
subscription-based digital pathology service for research purposes, mainly for
smaller labs that are unable to pay for high-end scanners.
In addition, implementation of sequencing
technology in tissue-based tests would significantly impact the progress rate
of this market. Major leaders like Roche are offering sequencing-based tissue
diagnostics products, thus aiding market growth.
Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market
https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market
Further key
findings from the report suggest:
- By technology, immunohistochemistry (IHC) dominated the market in
terms of revenue owing to its widespread usage across laboratories for
examining tissues for early disease diagnosis and prediction of therapy
response in cancer patients
- Digital pathology and workflow is expected to grow at the fastest
rate owing to rising investment in infrastructure and onsite server for
digitizing images. Furthermore, shortage of pathologists has spurred
automation in disease testing, thereby driving the segment
- High incidence of breast cancer, coupled with presence of several
products specifically designed for detection of this type of cancer, has
resulted in breast cancer accounting for the largest share by application.
Advancements in genomics for comprehensive understanding of the genetic
markup of a tumor are also anticipated to contribute to segment growth
- By end use, hospitals have led the overall market owing to high
hospitalization rate and subsequent adoption of these assays
- North America captured a major revenue share owing to presence of a
well-established regulatory framework for diagnostics. Furthermore,
growing collaboration between diagnostic and pharmaceutical companies in
U.S. is driving the regional market
- F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers, and QIAGEN
are some of the key participants in the market. These companies have been
investing significantly in novel product development and acquisition of
small payers in order to maintain their revenue share.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment